Chrystalle Katte T. Carreon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Death | 4 | 2022 | 434 | 2.030 |
Why?
|
Placenta | 11 | 2024 | 1702 | 1.540 |
Why?
|
Umbilical Cord | 2 | 2022 | 181 | 1.430 |
Why?
|
Choristoma | 2 | 2021 | 207 | 1.280 |
Why?
|
Heart Defects, Congenital | 7 | 2024 | 4673 | 1.140 |
Why?
|
Transposition of Great Vessels | 3 | 2023 | 590 | 0.890 |
Why?
|
Heart Valves | 2 | 2024 | 284 | 0.860 |
Why?
|
Dissection | 1 | 2024 | 297 | 0.820 |
Why?
|
Formaldehyde | 1 | 2023 | 358 | 0.760 |
Why?
|
Cardiomyopathies | 3 | 2024 | 1944 | 0.750 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2020 | 43 | 0.750 |
Why?
|
Chorionic Villi | 1 | 2020 | 53 | 0.740 |
Why?
|
Placenta Diseases | 4 | 2023 | 196 | 0.730 |
Why?
|
Heart Transplantation | 3 | 2024 | 3220 | 0.720 |
Why?
|
Renal Veins | 1 | 2020 | 102 | 0.710 |
Why?
|
Myocardium | 4 | 2023 | 4690 | 0.710 |
Why?
|
Ossification, Heterotopic | 2 | 2020 | 235 | 0.690 |
Why?
|
Immune System Diseases | 1 | 2021 | 258 | 0.650 |
Why?
|
Awards and Prizes | 1 | 2023 | 359 | 0.620 |
Why?
|
Appendix | 1 | 2019 | 110 | 0.610 |
Why?
|
Femoral Vein | 1 | 2018 | 153 | 0.600 |
Why?
|
Methadone | 1 | 2020 | 320 | 0.600 |
Why?
|
Fetus | 3 | 2022 | 1860 | 0.580 |
Why?
|
Vena Cava, Inferior | 1 | 2020 | 458 | 0.570 |
Why?
|
Myocarditis | 2 | 2021 | 766 | 0.570 |
Why?
|
Cysts | 1 | 2022 | 681 | 0.570 |
Why?
|
Cartilage | 1 | 2020 | 806 | 0.540 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 436 | 0.530 |
Why?
|
Troponin I | 1 | 2020 | 632 | 0.520 |
Why?
|
Heart Neoplasms | 1 | 2019 | 360 | 0.510 |
Why?
|
Saphenous Vein | 1 | 2018 | 517 | 0.510 |
Why?
|
Troponin T | 1 | 2020 | 761 | 0.500 |
Why?
|
Tachycardia, Ventricular | 2 | 2023 | 1297 | 0.470 |
Why?
|
Fetal Development | 1 | 2019 | 766 | 0.440 |
Why?
|
Pulmonary Artery | 2 | 2021 | 1916 | 0.440 |
Why?
|
Graft Survival | 1 | 2024 | 3794 | 0.440 |
Why?
|
Heart Ventricles | 3 | 2021 | 3806 | 0.430 |
Why?
|
Adenoma | 1 | 2023 | 2148 | 0.410 |
Why?
|
Arteritis | 1 | 2014 | 159 | 0.400 |
Why?
|
Heart | 6 | 2024 | 4382 | 0.380 |
Why?
|
Pregnancy | 16 | 2024 | 29742 | 0.370 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1292 | 0.370 |
Why?
|
Graft Rejection | 1 | 2024 | 4426 | 0.370 |
Why?
|
Eosinophilia | 1 | 2014 | 559 | 0.330 |
Why?
|
Heart Arrest | 1 | 2019 | 1494 | 0.320 |
Why?
|
Liver | 2 | 2022 | 7502 | 0.310 |
Why?
|
Thrombosis | 1 | 2022 | 2929 | 0.310 |
Why?
|
Imaging, Three-Dimensional | 1 | 2021 | 4048 | 0.310 |
Why?
|
Fibroma | 2 | 2022 | 190 | 0.280 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2142 | 0.250 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9575 | 0.230 |
Why?
|
Giant Cells | 2 | 2021 | 185 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3765 | 0.230 |
Why?
|
Humans | 45 | 2024 | 758381 | 0.230 |
Why?
|
Heart Valve Prosthesis | 2 | 2023 | 1466 | 0.230 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5797 | 0.220 |
Why?
|
Calmodulin | 1 | 2024 | 217 | 0.220 |
Why?
|
Granuloma, Plasma Cell | 1 | 2024 | 80 | 0.220 |
Why?
|
Infant, Newborn | 9 | 2024 | 26182 | 0.210 |
Why?
|
Ebstein Anomaly | 1 | 2023 | 101 | 0.210 |
Why?
|
Dystrophin | 1 | 2023 | 284 | 0.200 |
Why?
|
Female | 28 | 2024 | 390316 | 0.200 |
Why?
|
Immunohistochemistry | 4 | 2024 | 11070 | 0.200 |
Why?
|
Glycerol | 1 | 2023 | 275 | 0.200 |
Why?
|
Infant | 7 | 2024 | 36054 | 0.190 |
Why?
|
Oligonucleotides, Antisense | 1 | 2024 | 459 | 0.190 |
Why?
|
Single Umbilical Artery | 1 | 2021 | 3 | 0.190 |
Why?
|
Heart Aneurysm | 1 | 2021 | 114 | 0.190 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2023 | 491 | 0.180 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 268 | 0.180 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2022 | 167 | 0.180 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2020 | 55 | 0.180 |
Why?
|
Perfusion | 2 | 2022 | 1374 | 0.180 |
Why?
|
Echocardiography | 3 | 2024 | 4962 | 0.170 |
Why?
|
Transgenes | 1 | 2023 | 1007 | 0.170 |
Why?
|
Fibrosarcoma | 1 | 2022 | 308 | 0.170 |
Why?
|
Pregnancy Trimester, Second | 1 | 2022 | 732 | 0.170 |
Why?
|
Mitral Valve Stenosis | 1 | 2022 | 345 | 0.170 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 191 | 0.170 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2023 | 352 | 0.170 |
Why?
|
Tricuspid Valve | 1 | 2022 | 408 | 0.170 |
Why?
|
Stillbirth | 1 | 2022 | 368 | 0.170 |
Why?
|
Metaplasia | 1 | 2020 | 321 | 0.170 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2021 | 226 | 0.160 |
Why?
|
Aortic Valve Insufficiency | 1 | 2023 | 578 | 0.160 |
Why?
|
Biological Evolution | 1 | 2024 | 1074 | 0.160 |
Why?
|
Bioprosthesis | 1 | 2023 | 591 | 0.160 |
Why?
|
Codon, Nonsense | 1 | 2019 | 281 | 0.150 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 582 | 0.150 |
Why?
|
Chorioamnionitis | 1 | 2019 | 156 | 0.150 |
Why?
|
Retrospective Studies | 9 | 2024 | 80170 | 0.150 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 808 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 517 | 0.140 |
Why?
|
Autopsy | 1 | 2020 | 1003 | 0.140 |
Why?
|
Blood Coagulation | 1 | 2022 | 1149 | 0.130 |
Why?
|
Obstetrics | 1 | 2022 | 667 | 0.130 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1655 | 0.130 |
Why?
|
Child | 6 | 2024 | 79813 | 0.130 |
Why?
|
Biopsy | 3 | 2024 | 6768 | 0.130 |
Why?
|
Stromal Cells | 1 | 2020 | 1326 | 0.120 |
Why?
|
Male | 14 | 2024 | 358742 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6363 | 0.120 |
Why?
|
Calcinosis | 1 | 2023 | 1467 | 0.120 |
Why?
|
Muscle Proteins | 1 | 2019 | 1150 | 0.110 |
Why?
|
Reoperation | 1 | 2024 | 4282 | 0.110 |
Why?
|
Defibrillators, Implantable | 1 | 2023 | 1487 | 0.110 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1342 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1227 | 0.110 |
Why?
|
Child, Preschool | 5 | 2024 | 42058 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2019 | 818 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1152 | 0.110 |
Why?
|
Mammary Glands, Human | 1 | 2014 | 203 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2504 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2022 | 1401 | 0.100 |
Why?
|
Adolescent | 5 | 2024 | 87888 | 0.100 |
Why?
|
Coronary Aneurysm | 1 | 2014 | 231 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 2 | 2023 | 1554 | 0.100 |
Why?
|
Puerperal Disorders | 1 | 2014 | 299 | 0.090 |
Why?
|
Survival Analysis | 1 | 2024 | 10112 | 0.090 |
Why?
|
Hamartoma | 1 | 2013 | 235 | 0.090 |
Why?
|
Premature Birth | 1 | 2022 | 1771 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3565 | 0.090 |
Why?
|
Catheter Ablation | 1 | 2023 | 2740 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 12951 | 0.090 |
Why?
|
Sheep | 2 | 2023 | 1441 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2024 | 64379 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2942 | 0.080 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6457 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2024 | 8946 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39060 | 0.060 |
Why?
|
Sepsis | 1 | 2019 | 2587 | 0.060 |
Why?
|
Liver Diseases | 1 | 2013 | 1296 | 0.060 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2024 | 59 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2420 | 0.060 |
Why?
|
Placentation | 1 | 2024 | 78 | 0.060 |
Why?
|
Fever of Unknown Origin | 1 | 2024 | 94 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 2 | 2023 | 2248 | 0.060 |
Why?
|
Adnexal Diseases | 1 | 2024 | 106 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2014 | 3072 | 0.050 |
Why?
|
Infarction | 1 | 2023 | 247 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2023 | 527 | 0.050 |
Why?
|
Trophoblasts | 1 | 2023 | 224 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.050 |
Why?
|
Amniotic Fluid | 1 | 2023 | 378 | 0.050 |
Why?
|
Activating Transcription Factor 1 | 1 | 2020 | 26 | 0.050 |
Why?
|
Adult | 8 | 2024 | 219916 | 0.040 |
Why?
|
Long QT Syndrome | 1 | 2024 | 465 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 463 | 0.040 |
Why?
|
Incidental Findings | 1 | 2024 | 694 | 0.040 |
Why?
|
RNA-Binding Protein EWS | 1 | 2020 | 210 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2022 | 579 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2023 | 1829 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 539 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 490 | 0.040 |
Why?
|
Pelvis | 1 | 2022 | 743 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11594 | 0.040 |
Why?
|
Gene Fusion | 1 | 2020 | 354 | 0.040 |
Why?
|
Embryonic Development | 1 | 2022 | 716 | 0.040 |
Why?
|
Aorta, Thoracic | 1 | 2023 | 1094 | 0.040 |
Why?
|
Action Potentials | 1 | 2024 | 1816 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1751 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2038 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 29915 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2420 | 0.030 |
Why?
|
Mucinoses | 1 | 2014 | 1 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2023 | 1688 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2635 | 0.030 |
Why?
|
Fibroadenoma | 1 | 2014 | 41 | 0.030 |
Why?
|
Animals | 5 | 2024 | 167777 | 0.030 |
Why?
|
Mitral Valve | 1 | 2022 | 1466 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1842 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3298 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2731 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3400 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3046 | 0.020 |
Why?
|
Colonoscopy | 1 | 2019 | 1388 | 0.020 |
Why?
|
Heart Diseases | 1 | 2024 | 2782 | 0.020 |
Why?
|
Mesoderm | 1 | 2013 | 672 | 0.020 |
Why?
|
Intestines | 1 | 2019 | 1906 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14641 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14354 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6363 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15225 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4876 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 73806 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21017 | 0.020 |
Why?
|
Rats | 1 | 2023 | 23681 | 0.020 |
Why?
|
Young Adult | 2 | 2023 | 58808 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22031 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36285 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18125 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81107 | 0.020 |
Why?
|
Lung | 1 | 2022 | 9985 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29558 | 0.010 |
Why?
|
Carcinoma | 1 | 2014 | 2330 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 23883 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5952 | 0.010 |
Why?
|
Middle Aged | 1 | 2014 | 219560 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58681 | 0.010 |
Why?
|